Non-small cell lung carcinoma

GSTP1 Ile105Val and XRCC1 Arg399Gln gene polymorphisms contribute to the clinical outcome of patients with advanced non-small cell lung cancer

L. Bu, Zhang, L. B., Mao, X., Wang, P., Bu, L., Zhang, L. B., Mao, X., and Wang, P., GSTP1 Ile105Val and XRCC1 Arg399Gln gene polymorphisms contribute to the clinical outcome of patients with advanced non-small cell lung cancer, vol. 15, p. -, 2016.

Glutathione S-transferase P1 (GSTP1) and X-ray repair cross-complementing group 1 (XRCC1) genetic variations may in­fluence the efficacy of chemotherapy in various cancers. We investi­gated the possible roles of GSTP1 Ile105Val and XRCC1 Arg194Trp, and Arg399Gln gene polymorphisms in the prognosis of advanced non-small cell lung carcinoma (NSCLC) patients with cisplatin-based chemotherapy.

Relationship between serum leptin levels and non-small cell lung carcinoma: a meta-analysis

J. Du, Han, J. C., Zhang, Y. J., Qi, G. B., Zhang, Y., and Li, H. B., Relationship between serum leptin levels and non-small cell lung carcinoma: a meta-analysis, vol. 14, pp. 13699-13708, 2015.

In this study, we analyzed the association between serum leptin levels and non-small cell lung carcinoma (NSCLC). By examining English and Chinese databases, we identified potential relevant studies for statistical analysis. Human-associated case-control studies evaluating the association between serum leptin levels and NSCLC according to the random-effect model were retrieved and extracted data were statistically analyzed.

Expression and significance of myeloid differentiation factor 88 in non-small cell lung carcinoma and normal paracancerous tissues

J. Zhu, Li, Q., He, J., and Ma, K., Expression and significance of myeloid differentiation factor 88 in non-small cell lung carcinoma and normal paracancerous tissues, vol. 14, pp. 14239-14245, 2015.

We studied the expression level of myeloid differentiation factor 88 (MyD88) in non-small cell lung carcinoma (NSCLC) and normal paracancerous tissues, to determine its relationship with clinical pathological characteristics and prognosis. In total, 82 NSCLC patients who had received surgical treatment in our hospital between September 2008 and December 2013 were selected for this study. Another 82 normal paracancerous lung tissue samples were used as controls. All patients had complete clinical records, and they were followed-up for 5 years.

Subscribe to Non-small cell lung carcinoma